year 17, Issue 1 (January - February 2023)                   Iran J Med Microbiol 2023, 17(1): 112-116 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Pourmomen M, Younesian O, Hosseinzadeh S, Hosseini Alarzi S S, Pourmomen M, Joshaghani H. Frequency of Influenza Infection in Symptomatic Patients Suspected of Having COVID-19. Iran J Med Microbiol 2023; 17 (1) :112-116
URL: http://ijmm.ir/article-1-1786-en.html
1- Department of Microbiology, Gorgan Branch, Islamic Azad University, Gorgan, Iran
2- School of Medicine, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran
3- Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran
4- Department of Medical Biotechnology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran
5- Department of Biology, Gorgan Branch, Islamic Azad University, Gorgan, Iran
6- Department of Biochemistry, Kavosh Pathobiology and Genetic Laboratory, Gorgan, Iran , joshaghani@goums.ac.ir
Abstract:   (1215 Views)

Background and Aim: About one billion people have infected with the influenza A virus each year. The continued spread of SARS-CoV-2 especially in the winter season may increase the co-infection of SARS-CoV-2 with other respiratory viruses, which may worsen the severity of the disease and increase mortality. In respiratory infections, primary identification of the underlying source of infection is necessitated to find appropriate treatment and to improve individual patient management. Therefore, it is essential to accurately and immediately diagnose these two diseases. This study aimed to assess the frequency of influenza A, influenza B, and COVID-19 among individuals suspected of having a respiratory infection.
Materials and Methods: In this study, 861 patients presenting from 19 November 2021 to 18 January 2022 in Kavosh medical laboratory (Golestan, Gorgan, Iran) with suspected viral respiratory tract infection who underwent RT-PCR testing for SARS-CoV-2/influenza were included. Data analysis was performed using appropriate descriptive statistics.
Results & Conclusion: A total of 184 patients were confirmed with COVID-19/influenza. 90 patients with COVID-19 (48.9%) and 94 patients (51.1%) with influenza (92 with influenza A and 2 with influenza B) were collected in the present study. The influenza/COVID-19 ratio was 1/0.95. Two cases of co-infection with COVID-19/influenza were observed. During the influenza season, the influenza/COVID-19 ratio in patients with suspected respiratory infection was 1/0.95. Patients with influenza were significantly younger than patients with COVID-19 and the proportion of males and females was not meaningfully different in the COVID-19 and influenza patients.

Full-Text [PDF 445 kb]   (420 Downloads) |   |   Full-Text (HTML)  (382 Views)  
Type of Study: Brief Original Article | Subject: Medical Virology
Received: 2022/06/14 | Accepted: 2022/10/10 | ePublished: 2023/01/20

References
1. Ghavidel S, Emami M. Influenza global scholarly publications in the mirror of the co-word analysis technique. Iran J Med Microbiol. 2020;15(4):400-13. [DOI:10.30699/ijmm.15.4.400]
2. Parvizi P, Jalilian M, Parvizi H, Amiri S, Mohammad Doust H. The COVID-19 pandemic: Data analysis, impacts and future considerations. Iran J Med Microbiol. 2021;15(1):1-17. [DOI:10.30699/ijmm.15.1.1]
3. Kinoshita T, Watanabe K, Sakurai Y, Nishi K, Yoshikawa R, Yasuda J. Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters. Sci Rep. 2021;11(1):21259. [DOI:10.1038/s41598-021-00809-2] [PMID] [PMCID]
4. Zhang N, Wang L, Deng X, Liang R, Su M, He C, et al. Recent advances in the detection of respiratory virus infection in humans. J Med Virol. 2020;92(4):408-17. [DOI:10.1002/jmv.25674] [PMID] [PMCID]
5. Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, et al. Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano. 2020;14(4):3822-35. [DOI:10.1021/acsnano.0c02624] [PMID] [PMCID]
6. Leung EC, Chow VC, Lee MK, Tang KP, Li DK, Lai RW. Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens. J Clin Microbiol. 2021;59(4). [DOI:10.1128/JCM.02965-20] [PMID] [PMCID]
7. Khademi Sayed Bonadaki ZS, Madani R, Pakzad P, Golchinfar F, Emami T. Evaluating the Immunogenicity of Avian Influenza Virus Nucleoprotein. Iran J Med Microbiol. 2020;14(6):643-59. [DOI:10.30699/ijmm.14.6.643]
8. Javid Khojasteh V, Mojtahedi A, Hosseini S, Joukar F. Relative frequency of influenza A/H1N1 virus in Guilan province, Iran. Iran J Med Microbiol. 2017;11(5):83-9.
9. Caini S, Kusznierz G, Garate VV, Wangchuk S, Thapa B, de Paula Júnior FJ, et al. The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century. PLoS One. 2019;14(9):e0222381. [DOI:10.1371/journal.pone.0222381] [PMID] [PMCID]
10. Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nat Rev Microbiol. 2018;16(1):47-60. [DOI:10.1038/nrmicro.2017.118] [PMID]
11. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266-75. [DOI:10.1016/j.jinf.2020.05.046] [PMID] [PMCID]
12. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020;323(20):2085-6. [DOI:10.1001/jama.2020.6266] [PMID] [PMCID]
13. Brehm TT, van der Meirschen M, Hennigs A, Roedl K, Jarczak D, Wichmann D, et al. Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza. Sci Rep. 2021;11(1):5803. [DOI:10.1038/s41598-021-85081-0] [PMID] [PMCID]
14. Zhang J, Ding D, Huang X, Zhang J, Chen D, Fu P, et al. Differentiation of COVID-19 from seasonal influenza: A multicenter comparative study. J Med Virol. 2021;93(3):1512-9. [DOI:10.1002/jmv.26469] [PMID] [PMCID]
15. Faury H, Courboulès C, Payen M, Jary A, Hausfater P, Luyt C, et al. Medical features of COVID-19 and influenza infection: A comparative study in Paris, France. J Infect. 2021;82(2):e36-e9. [DOI:10.1016/j.jinf.2020.08.017] [PMID] [PMCID]
16. Mukherjee S, Pahan K. Is COVID-19 Gender-sensitive? J Neuroimmune Pharmacol. 2021;16(1):38-47. [DOI:10.1007/s11481-020-09974-z] [PMID] [PMCID]
17. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29. [DOI:10.1186/s13293-020-00304-9] [PMID] [PMCID]
18. Aleksanyan Y, Weinman JP. Women, men and COVID-19. Soc Sci Med. 2022;294:114698. [DOI:10.1016/j.socscimed.2022.114698] [PMID] [PMCID]
19. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis. 2003;37(8):1094-101. [DOI:10.1086/378292] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc